These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 35983034)

  • 21. CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1.
    Perez-Villar JJ; Whitney GS; Bowen MA; Hewgill DH; Aruffo AA; Kanner SB
    Mol Cell Biol; 1999 Apr; 19(4):2903-12. PubMed ID: 10082557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shp2, an SH2-containing protein-tyrosine phosphatase, positively regulates receptor tyrosine kinase signaling by dephosphorylating and inactivating the inhibitor Sprouty.
    Hanafusa H; Torii S; Yasunaga T; Matsumoto K; Nishida E
    J Biol Chem; 2004 May; 279(22):22992-5. PubMed ID: 15031289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Negative regulation of gp130 signalling mediated through tyrosine-757 is not dependent on the recruitment of SHP2.
    Fairlie WD; De Souza D; Nicola NA; Baca M
    Biochem J; 2003 Jun; 372(Pt 2):495-502. PubMed ID: 12593670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular interactions of SHP1 and SHP2 in IL-3-signalling.
    Wheadon H; Paling NR; Welham MJ
    Cell Signal; 2002 Mar; 14(3):219-29. PubMed ID: 11812650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular recognition of ITIM/ITSM domains with SHP2 and their allosteric effect.
    Cheng Y; Ouyang W; Liu L; Tang L; Zhang Z; Yue X; Liang L; Hu J; Luo T
    Phys Chem Chem Phys; 2024 Mar; 26(12):9155-9169. PubMed ID: 38165855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases.
    Chen YN; LaMarche MJ; Chan HM; Fekkes P; Garcia-Fortanet J; Acker MG; Antonakos B; Chen CH; Chen Z; Cooke VG; Dobson JR; Deng Z; Fei F; Firestone B; Fodor M; Fridrich C; Gao H; Grunenfelder D; Hao HX; Jacob J; Ho S; Hsiao K; Kang ZB; Karki R; Kato M; Larrow J; La Bonte LR; Lenoir F; Liu G; Liu S; Majumdar D; Meyer MJ; Palermo M; Perez L; Pu M; Price E; Quinn C; Shakya S; Shultz MD; Slisz J; Venkatesan K; Wang P; Warmuth M; Williams S; Yang G; Yuan J; Zhang JH; Zhu P; Ramsey T; Keen NJ; Sellers WR; Stams T; Fortin PD
    Nature; 2016 Jul; 535(7610):148-52. PubMed ID: 27362227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein Kinase A (PKA) Phosphorylation of Shp2 Protein Inhibits Its Phosphatase Activity and Modulates Ligand Specificity.
    Burmeister BT; Wang L; Gold MG; Skidgel RA; O'Bryan JP; Carnegie GK
    J Biol Chem; 2015 May; 290(19):12058-67. PubMed ID: 25802336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting Src homology 2 domain-containing tyrosine phosphatase (SHP-1) into lipid rafts inhibits CD3-induced T cell activation.
    Su MW; Yu CL; Burakoff SJ; Jin YJ
    J Immunol; 2001 Mar; 166(6):3975-82. PubMed ID: 11238643
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Marasco M; Kirkpatrick JP; Carlomagno T
    Biomol NMR Assign; 2020 Oct; 14(2):179-188. PubMed ID: 32236803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyphyllin D Shows Anticancer Effect through a Selective Inhibition of Src Homology Region 2-Containing Protein Tyrosine Phosphatase-2 (SHP2).
    Kwon SJ; Ahn D; Yang HM; Kang HJ; Chung SJ
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33562835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular basis of gain-of-function LEOPARD syndrome-associated SHP2 mutations.
    Yu ZH; Zhang RY; Walls CD; Chen L; Zhang S; Wu L; Liu S; Zhang ZY
    Biochemistry; 2014 Jul; 53(25):4136-51. PubMed ID: 24935154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the reason for increased activity of SHP2 caused by D61Y mutation through molecular dynamics.
    Wang RR; Ma Y; Du S; Li WY; Sun YZ; Zhou H; Wang RL
    Comput Biol Chem; 2019 Feb; 78():133-143. PubMed ID: 30508783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Activity of Src Homology 2 Domain Containing Phosphotyrosine Phosphatase 2 (Shp2) Regulates Activity-dependent AMPA Receptor Trafficking.
    Zhang B; Du YL; Lu W; Yan XY; Yang Q; Yang W; Luo JH
    J Biol Chem; 2016 Sep; 291(36):18856-66. PubMed ID: 27417137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discriminating between competing models for the allosteric regulation of oncogenic phosphatase SHP2 by characterizing its active state.
    Calligari P; Santucci V; Stella L; Bocchinfuso G
    Comput Struct Biotechnol J; 2021; 19():6125-6139. PubMed ID: 34900129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation.
    Hadari YR; Kouhara H; Lax I; Schlessinger J
    Mol Cell Biol; 1998 Jul; 18(7):3966-73. PubMed ID: 9632781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanism of SHP2 activation by PD-1 stimulation.
    Marasco M; Berteotti A; Weyershaeuser J; Thorausch N; Sikorska J; Krausze J; Brandt HJ; Kirkpatrick J; Rios P; Schamel WW; Köhn M; Carlomagno T
    Sci Adv; 2020 Jan; 6(5):eaay4458. PubMed ID: 32064351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration.
    Voena C; Conte C; Ambrogio C; Boeri Erba E; Boccalatte F; Mohammed S; Jensen ON; Palestro G; Inghirami G; Chiarle R
    Cancer Res; 2007 May; 67(9):4278-86. PubMed ID: 17483340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
    Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
    J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Docking protein Gab2 is phosphorylated by ZAP-70 and negatively regulates T cell receptor signaling by recruitment of inhibitory molecules.
    Yamasaki S; Nishida K; Hibi M; Sakuma M; Shiina R; Takeuchi A; Ohnishi H; Hirano T; Saito T
    J Biol Chem; 2001 Nov; 276(48):45175-83. PubMed ID: 11572860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.